Poloxalkol R (pluronic F-68): a priming solution for cardiopulmonary bypass.
D000818:Animals; D001772:Blood Cell Count; D001773:Blood Cells / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects; D001784:Blood Gas Analysis; D001798:Blood Proteins / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005112:Extracorporeal Circulation; D005947:Glucose / Q000627:therapeutic use; D006400:Hematocrit; D006454:Hemoglobins; D006461:Hemolysis; D006863:Hydrogen-Ion Concentration; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010477:Perfusion; D010952:Plasma Substitutes / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010973:Platelet Adhesiveness / Q000187:drug effects; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000627:therapeutic use*
D001798:Blood Proteins; D006454:Hemoglobins; D010952:Plasma Substitutes; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D005947:Glucose; D010100:Oxygen